National Health Investors (NHI) Stock Price, News & Analysis

-0.70 (-1.11%)
(As of 10:03 AM ET)
Today's Range
50-Day Range
52-Week Range
2,305 shs
Average Volume
170,480 shs
Market Capitalization
$2.70 billion
P/E Ratio
Dividend Yield
Price Target

National Health Investors MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
3.7% Downside
$60.50 Price Target
Short Interest
2.11% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.24mentions of National Health Investors in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$586,900 Bought Last Quarter
Proj. Earnings Growth
From $4.34 to $4.54 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.52 out of 5 stars

Finance Sector

161st out of 859 stocks

Real Estate Investment Trusts Industry

29th out of 181 stocks

NHI stock logo

About National Health Investors Stock (NYSE:NHI)

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

NHI Stock Price History

NHI Stock News Headlines

Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Canadian Diplomats Dispute Havana Study Findings
National Health Investors Inc
Q4 2023 National Health Investors Inc Earnings Call
See More Headlines
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 1/26 Dividend
Dividend Payable
Ex-Dividend for 5/3 Dividend
Dividend Payable
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Real estate investment trusts
Specialized REITs
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
8 Analysts


Net Income
$135.65 million
Pretax Margin


Sales & Book Value

Annual Sales
$319.83 million
Cash Flow
$4.93 per share
Book Value
$29.13 per share


Free Float
Market Cap
$2.73 billion

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. D. Eric Mendelsohn (Age 62)
    President, CEO & Director
    Comp: $1.38M
  • Mr. John L. Spaid (Age 64)
    Executive VP of Finance, CFO & Treasurer
    Comp: $809.9k
  • Mr. Kevin Carlton Pascoe (Age 43)
    Executive VP & Chief Investment Officer
    Comp: $702.16k
  • Mr. David Louis Travis (Age 49)
    Senior VP & Chief Accounting Officer
    Comp: $534.9k
  • Ms. Kristin Sallee Gaines (Age 52)
    Senior VP & Chief Transaction Officer
    Comp: $570.9k
  • Mr. Dana Rolfson Hambly
    Director of Investor Relations
  • Mr. Kimberly Ouimet
    Director of Corporate Compliance & Human Resources
  • Ms. Michelle R. Kelly
    Senior Vice President of Investments
  • Susan V. Sidwell
    Corporate Secretary
  • Ms. Colleen Schaller
    Real Estate Transaction Manager

NHI Stock Analysis - Frequently Asked Questions

Should I buy or sell National Health Investors stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NHI shares.
View NHI analyst ratings
or view top-rated stocks.

What is National Health Investors' stock price target for 2024?

8 brokers have issued 12 month price objectives for National Health Investors' shares. Their NHI share price targets range from $52.00 to $69.00. On average, they predict the company's stock price to reach $60.50 in the next year. This suggests that the stock has a possible downside of 3.7%.
View analysts price targets for NHI
or view top-rated stocks among Wall Street analysts.

How have NHI shares performed in 2024?

National Health Investors' stock was trading at $55.85 at the beginning of the year. Since then, NHI shares have increased by 12.5% and is now trading at $62.85.
View the best growth stocks for 2024 here

When is National Health Investors' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our NHI earnings forecast

How can I listen to National Health Investors' earnings call?

National Health Investors will be holding an earnings conference call on Tuesday, May 7th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) released its quarterly earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 EPS for the quarter, missing the consensus estimate of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to analysts' expectations of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 10.65% and a net margin of 42.40%. National Health Investors's quarterly revenue was down 11.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.24 earnings per share.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors declared a quarterly dividend on Tuesday, February 20th. Investors of record on Thursday, March 28th will be paid a dividend of $0.90 per share on Friday, May 3rd. This represents a $3.60 dividend on an annualized basis and a yield of 5.73%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for NHI

Is National Health Investors a good dividend stock?

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 5.74%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 79.30% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors issued an update on its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided EPS guidance of 4.310-4.370 for the period, compared to the consensus earnings per share estimate of 4.330. The company issued revenue guidance of -.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a number of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.94%), Nepsis Inc. (0.13%), Pensionfund DSM Netherlands (0.09%), Raymond James Financial Services Advisors Inc. (0.06%), Pensionfund Sabic (0.04%) and DGS Capital Management LLC (0.01%). Insiders that own company stock include Charlotte A Swafford, James R Jobe, Robert G Adams and Robert T Webb.
View institutional ownership trends

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NHI) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners